C.R. Bard closes federal cancer treatment beef for $51M

May 13, 2013 by Brad Perriello

C.R. Bard closes the deal it made last year with federal authorities to settle a probe into its brachytherapy cancer treatment business in return for a $51 million payment.

C.R. Bard closes federal cancer treatment beef for $51M

C.R. Bard (NYSE:BCR) said it closed a deal reached last year with federal prosecutors to settle a probe into its brachytherapy business with a $51 million payment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp